dutastéride
Dutasteride is a medication classified as a 5-alpha-reductase inhibitor. Its primary use is in the treatment of symptomatic benign prostatic hyperplasia (BPH), also known as an enlarged prostate. By inhibiting both type 1 and type 2 isoforms of 5-alpha-reductase, dutasteride reduces the conversion of testosterone to dihydrotestosterone (DHT). DHT is a key hormone responsible for the growth of prostate tissue. Lowering DHT levels can lead to a decrease in prostate size and an improvement in urinary symptoms associated with BPH, such as difficulty urinating, weak urine stream, and frequent urination, especially at night.
In addition to BPH, dutasteride is also approved in some regions for the treatment of male pattern
Dutasteride is taken orally, typically once daily. It is important to note that this medication may take